Abstract
Iron, like other metals, is not destroyed within the body and therefore, in order to limit its biological and/or toxic effects, must be eliminated. Various elimination pathways exist physiologically, ensuring a balance with the amount of iron absorbed by the intestine, Le.1 to 2 mg per day corresponding to about 10 per cent of a normal diet containing 10-20 mg of iron 1. Iron losses occur mainly through exfoliated intestinal epithelial cells, smaller amounts being lost via the skin (desquamated cells and sweat) or by urinary route (0.1 mg daily). The biliary elimination of iron has classically been considered as a minor pathway. However, recent data from both human and experimental studies emphasize the importance of the biliary excretion route.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. Brissot and Y. Deugnier, Normal iron metabolism. Oxford Textbook of Clinical Hepatology, Ed. N Mclntyre, JP Benhamou, J Bircher, M Rizzetto and J Rodes, Oxford University Press 221 (1991).
R. Green, R. Charlton, H. Seftel, T. Bothwell, F. Mayet, B. Adams, C. Finch, and M. Layrisse, Body iron excretion in man, A collaborative study, Am J Physiol 45: 336 (1968).
R. Hultcrantz, B. Angelin, E. Björn-Rasmussen, S. Ewerth, and K. Einarsson, Biliary excretion of iron and ferritin in idiopathic hemochromatosis, Gastroenterology 96: 1539 (1989).
K. Einarsson, K. Nilsell, B. Leidj, and B. Angelin, Influence of age on secretion of cholesterol and synthesis of bile acids by the liver, N Engl J Med 313: 277 (1985).
R. Raedsch, A. Stiehl, S. Walker, L. Theilmann, B. Kommerell, R. Waldherr, and M. Senn, Biliary excretion of iron in healthy man and in patients with alcoholic cirrhosis of the liver, Clin Chim Acta 193: 49 (1990).
A. Jacobs and P.M. Miles, The formation of iron complexes with bile and bile constituents, Gut 11: 732 (1970).
N.F. LaRusso, Proteins in bile: how they get there and what they do, Am J Physiol 247: G 199 (1984).
T.C. Iancu, Ultrastructural pathology of iron overload, Baillière’s Clin Haematol 2: 475 (1989).
Y. Deugnier, O. Loréal, B. Turlin, D. Guyader, H. Jouanolle, R. Moirand, C. Jacquelinet, and P. Brissot, Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations, Gastroenterology 102: 2050 (1992).
M. Cleton, J.W. Sindram, L.P.M. Rademakers, F.M.J. Zuyderhoudt, W.C. De Bruijn, and J.J.M. Marx, Ultrastructural evidence for the presence of ferritin-iron in the biliary system of patients with iron overload, Hepatology 6: 30 (1986).
P.J. Scheuer. Liver biopsy interpretation. 2nd ed. London: Baillère. Tindall and Cassell 1977.
Y.M. Deugnier, A.F. Rabot, R. Moirand, D. Le Quilleuc, D. Guyader, C. Jacquelinet, B. Turlin, and P. Brissot, Serum increase and liver overexpression of the carbohydrate 19.9 antigen in patients with untreated genetic hemochromatosis, Abst 4th International Conference on hemochromatosisi and Clinical Problems in Iron Metabolism, Jerusalem (April 27-May 1, 1993).
W.D. Bradford, J.G. Elchlepp, A.U. Arstila, B.F. Trump, and T.D. Kinney, Iron metabolism and cell membranes, I Relation between ferritin and hemosiderin in bile and biliary excretion of lysosome contents, Am J Pathol 56: 201 (1969).
P. Brissot, J. Farjanel, D. Bourel, J.P. Campion,Guillouzo, A. Rattner, Y. Deugnier, B. Desvergne, B. Ferrand, M. Simon, and M. Bourel, Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional changes with special emphasis to collagen synthesis enzymes, Dig Dis Sci 32: 620 (1987).
R.T. Parmley, M.E. May, S.S. Spicer, M.G. Buse, and C.J. Alvarez, Ultrastructural distribution of inorganic iron in normal and iron-overloaded hepatic cells, Lab Invest 44: 475 (1981).
B.R. Bacon, A.S. Tavill, G.M. Brittenham, C.H. Park and R.O. Recknagel, Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J Clin Invest 71: 429 (1983).
C.H. Park, B.R. Bacon, G.M. Brittenham, and A.S. Tavill, Pathology of dietary carbonyl iron overload in rats, Lab Invest 57: 555 (1987).
G.D. LeSage, L.J. Kost, S.S. Barham, and N.F. LaRusso, Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload, J Clin Invest 77: 90 (1986).
P. Lévy, M. Dumont, P. Brissot, A. Letreut, A. Favier, Y. Deugnier, and S. Erlinger, Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats, Gastroenterology 101: 1673 (1991).
R.A. Marinelli, C.E. Carnovale, and E.A. Rodriguez Garay, Bile protein secretion in the rat stimulated by taurocholate: effect of chloroquine, Can J Physiol Pharmacol. 66: 749 (1988).
K. Rahman and R. Coleman, Output of lysosomal contents and cholesterol into bile can be stimulated by taurodehydrocholate, Biochem J 245: 289 (1987).
P. Brissot, T.L. Wright, W.L. Ma, and R.A. Weisiger, Efficient clearance of non-transferrin-bound iron by rat liver: Implications for hepatic iron loading in iron overload states, J Clin Invest 76: 1463 (1986).
T.L. Wright, P. Brissot, W.L. Ma, and R.A. Weisiger, Characterization of non-transferrin bound iron clearance by rat liver, J Biol Chem 261: 10909 (1986).
D. Guyader, G. Zanninelli, and P. Brissot, Fer non lié à la transferrine et charge hépatique en fer, Gastroenterol Clin Biol 16: 756 (1992).
P. Brissot, G. Zanninelli, D. Guyader, J. Zeind, and J. Gollan, Biliary excretion of plasma non-transferrin-bound iron: a significant excretory pathway in normal but not in chronically iron overloaded rats, Am J Physiol (in press).
J.B. Porter, E.R. Huehns, and R.C. Hider, The development of iron chelating drugs, Baillière’s Clin Haematol 2: 257 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brissot, P. et al. (1994). Iron Overload and the Biliary Route. In: Hershko, C., Konijn, A.M., Aisen, P. (eds) Progress in Iron Research. Advances in Experimental Medicine and Biology, vol 356. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2554-7_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2554-7_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6090-2
Online ISBN: 978-1-4615-2554-7
eBook Packages: Springer Book Archive